Researchers published a Nature Communications study showing that combining bacteriophage therapy with standard antibiotics cleared refractory, drug‑resistant Klebsiella pneumoniae peritonitis in preclinical models tied to peritoneal dialysis infections. The team led by Yang, Wu and Jiang highlighted phage‑antibiotic synergy as a pathway to rescue infections that fail conventional therapy. Separately, a research report described a novel genetic platform aimed at reversing or mitigating resistance traits in microbial populations. Together, the studies mark converging therapeutic strategies — combining biologic antimicrobials with genetic or molecular technologies — to address hospital and environmental drivers of antimicrobial resistance.